Xu J, Xu L, Wei X, Li X, Cai M
Medical School of Chinese People's Liberation Army, the Chinese People's Liberation Army General Hospital, Beijing, China; Organ Transplant Institute of People's Liberation Army, Beijing Key Laboratory of Immunology Regulatory and Organ Transplantation, the 309th Hospital of People's Liberation Army, Beijing, China.
Organ Transplant Institute of People's Liberation Army, Beijing Key Laboratory of Immunology Regulatory and Organ Transplantation, the 309th Hospital of People's Liberation Army, Beijing, China.
Transplant Proc. 2018 Dec;50(10):3381-3385. doi: 10.1016/j.transproceed.2018.08.007. Epub 2018 Aug 9.
Posttransplantation diabetes mellitus (PTDM) is a frequent metabolic complication following solid organ transplantation and was proven to be associated with adverse outcome. This study aimed to identify the incidence and risk factors of PTDM under the background of relative-living renal transplantation in China.
We conducted a retrospective cohort study that included 358 recipients who underwent relative-living donor kidney transplantation in the Organ Transplant Institute of 309th Hospital of People's Liberation Army between January 1, 2010, and December 31, 2014. PTDM was defined based on American Diabetes Association criteria. Demographics and laboratory results were compared between patients with PTDM and non-PTDM; multivariate analysis was performed using a logistic regression model.
One hundred ten out of a total of 358 recipients were diagnosed with PTDM (30.72%) within 3 years after transplantations. Seven risk factors for PTDM were identified in multivariate analysis: body mass index ≥25 (odds ratio [OR] 1.905, 95% confidence interval [CI]: 1.114-3.258), family history of diabetes (OR 1.898, CI: 1.051-3.258), hypomagnesemia pretransplantation (OR 1.871, CI: 1.133-3.092), acute rejection episodes in 3 months posttransplantation (OR 2.312, CI: 1.015-5.268), tacrolimus use (OR 1.952, CI: 1.169-3.258), impaired fasting glucose diagnosed pretransplantation (OR 1.807, CI: 1.091-2.993), and hyperglycemia in the first week posttransplantation (OR 1.856, CI: 1.133-3.043).
Our study suggests high body mass index, family diabetes history, hypomagnesemia pretransplantation, acute rejection episodes within the first 3 months after transplantation, tacrolimus use, impaired fasting glucose diagnosed pretransplantation, and hyperglycemia within the first week after transplantation are independent risk factors of PTDM in relative-living donor transplantation.
移植后糖尿病(PTDM)是实体器官移植后常见的代谢并发症,且已被证实与不良预后相关。本研究旨在确定中国亲属活体肾移植背景下PTDM的发生率及危险因素。
我们进行了一项回顾性队列研究,纳入了2010年1月1日至2014年12月31日期间在解放军第309医院器官移植研究所接受亲属活体供肾移植的358例受者。PTDM根据美国糖尿病协会标准定义。对发生PTDM和未发生PTDM的患者的人口统计学和实验室检查结果进行比较;使用逻辑回归模型进行多因素分析。
358例受者中,110例(30.72%)在移植后3年内被诊断为PTDM。多因素分析确定了PTDM的7个危险因素:体重指数≥25(比值比[OR]1.905,95%置信区间[CI]:1.114 - 3.258)、糖尿病家族史(OR 1.898,CI:1.051 - 3.258)、移植前低镁血症(OR 1.871,CI:1.133 - 3.092)、移植后3个月内发生急性排斥反应(OR 2.312,CI:1.015 - 5.268)、使用他克莫司(OR 1.952,CI:1.169 - 3.258)、移植前诊断为空腹血糖受损(OR 1.807,CI:1.091 - 2.993)以及移植后第一周出现高血糖(OR 1.856,CI:1.133 - 3.043)。
我们的研究表明,高体重指数、糖尿病家族史、移植前低镁血症、移植后前3个月内的急性排斥反应、使用他克莫司、移植前诊断为空腹血糖受损以及移植后第一周出现高血糖是亲属活体供肾移植中PTDM的独立危险因素。